Physician profile
James E Simony, II
NPI 1710919865
$740.59
in general payments reported to CMS, 2019-2025
14 companies · $186 in 2025
The $186 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $79.55 · 2021: $38.97 · 2022: $176 · 2023: $82.63 · 2024: $178 · 2025: $186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $446.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $446.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $234.88 | 2020-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Sobi, INC | $135.42 | 2020-2023 | |
| Seqirus USA INC | $96.66 | 2021-2025 | Flucelvax |
| Sanofi Pasteur INC. | $60.69 | 2020-2023 | |
| Vertical Pharmaceuticals, LLC | $48.80 | 2024 | Relexxii |
| Kowa Pharmaceuticals America, INC. | $31.47 | 2025 | Zoryve |
| Genzyme Corporation | $25.24 | 2022 | |
| Lnhc, INC | $20.18 | 2025 | Zelsuvmi |
| Genentech USA, INC. | $17.48 | 2020 | |
| Advanced Respiratory, INC | $15.41 | 2020 | |
| Pfizer INC. | $13.99 | 2025 | |
| Glaxosmithkline, LLC. | $13.99 | 2022 | |
| Biomerieux INC | $13.48 | 2025 | |
| Ultragenyx Pharmaceutical INC. | $12.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Simony listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.